Validation of an Adjusted Dosing Algorithm of Carboplatin

Summary

An adjusted dosing algorithm for the dosing of the anticancer drug carboplatin has been developed, that accounts for high BMI, low serum creatinine values and maximal calculated renal function. The hypothesis is that this new dosing algorithm provides a more accurate and safe dose than dosing according to the old standard of care.

Timeline

Start

2014-09

Primary completion

2015-09

Completion

2015-12

Drugs

Indications